30.36  0.02 (0.07%)		05-16 16:00
Open: 30.36 High: 30.36 Volume: 2,096		Pre. Close: 30.34 Low: 30.27 Market Cap: 59(M)

Short term
Mid term
Targets	6-month :	35.46	1-year :	41.41
Resists	First :	30.36	Second :	35.46
Pivot price	29.37
Supports	First :	28.9	Second :	28.01
MAs	MA(5) :	29.93	MA(20) :	29.18
	MA(100) :	29.08	MA(250) :	27.79
MACD	MACD :	0.2	Signal :	0
%K %D	K(14,3) :	100	D(3) :	97.2
RSI	RSI(14): 71.1
52-week	High :	30.59	Low :	24.4

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ AGNG ] has closed below upper band by 2.8%. Bollinger Bands are 64.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	30.38 - 30.47	30.47 - 30.57
Low:	29.99 - 30.1	30.1 - 30.23
Close:	30.16 - 30.33	30.33 - 30.52

The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.

Sat, 11 May 2024
Global X Aging Population ETF (NASDAQ:AGNG) Short Interest Down 92.5% in April - Defense World

Mon, 26 Feb 2024
The 3 Hottest Healthcare ETFs to Buy in 2024 - InvestorPlace

Fri, 16 Feb 2024
In the Pipeline: Top Drug Candidates for FDA Approval in 2024 - Global X

Fri, 12 Jan 2024
Two industries where Einstein would invest - Finimize

Wed, 28 Jun 2023
ASCO Annual Meeting 2023: Precision Oncology Achieving Widespread Adoption - Global X

Fri, 20 Jan 2023
Another Year of Blockbuster Drug and Treatment Approvals Possible in 2023 - Global X

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management - Global
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.